Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis

Journal of Hepatology

Volumn 24, Issue 3, 1996, Pages 271-276

  Tsai, Jung Fa ^a   Jeng, Jen Eing ^b   Ho, Mei Shang ^b   Chang, Wen Yu ^b   Lin, Zu Yau ^b   Tsai, Juei Hsiung ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NONE

Author keywords

antibody to hepatitis C virus; chronic hepatitis; hepatitis B surface antigen

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0029962815     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80004-3     Document Type: Article

References (35)

1. Alter MJ, Margolis HS, Klawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899-905.
2. Yano M, Yatsuhashi H, Inoue O, Inokuchi K, Koga M. Epidemiology and long-term prognosis of hepatitis C virus infection in Japan. Gut 1993; 34 (Suppl): S13-6.
3. Jeng JE, Tsai JF. Hepatitis C virus antibody in hepatocellular carcinoma in Taiwan. J Med Virol 1991; 34: 74-7.
4. Tsai JF, Chang WY, Jeng JE, Ho MS, Wang LY, Hsieh MY, Chen SC, Chuang WL, Lin ZY, Tsai JH. Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J Med Virol 1993; 41: 296-300.
5. Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY, Tsai JH. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver 1994; 14: 98-102.
6. Tsai JF, Jeng JE, Ho MS, Chang WY, Lin ZY, Tsai JH. Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: a case-control study. Int J Cancer 1994; 56: 619-21.
7. Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY, Tsai JH. Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma. J Med Virol 1994; 44: 92-5.
8. Tsai JF, Jeng JE, Chang WY, Lin ZY, Tsai JH. Hepatitis C virus infection among patients with chronic liver disease in an area hyperendemic for hepatitis B. Scand J Gastroenterol 1994; 29: 550-2.
9. Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY, Tsai JH. Frequency of raised α-fetoplotein level among Chinese patients with hepatocellular carcinoma. Br J Cancer 1994; 69: 1157-9.
10. Tsai JF, Margolis HS, Jeng JE, Ho MS, Ko YC, Lin ZY, Chang WY, Tsai JH. Association between hepatitis B and C virus infection and Chinese hepatocellular carcinoma. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral Hepatitis and Liver Disease. Tokyo: Springer-Verlag, 1994: 697-700.
11. Tsai JF, Jeng JE, Chang WY, Ho MS, Lin ZY, Tsai JH. Circulating immune complexes in chronic hepatitis C. J Med Virol 1995; 46: 12-7.
12. Tsai SL, Liaw YF, Yeh CT, Chu CM, Kuo GC. Cellular immune responses in patients with dual infection of hepatitis B and C viruses: dominant role of hepatitis C virus. Hepatology 1995; 21: 908-12.
13. Chen DS. Natural history of chronic hepatitis B virus infection: new light on an old Story. J Gastroenterol Hepatol 1993; 8: 470-5.
14. Liaw YF. Viral hepatitis in Taiwan: status in the 1990s. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral Hepatitis and Liver Disease. Tokyo: Springer-Verlag, 1994: 419-21.
15. Alberti A, Pontisso P, Chemello L, Fattovich G, Benvegnu L Belussi F, De Mitri MS. The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease. J Hepatol 1995; 22 (Suppl. 1): 38-41.
16. Ohkawa K, Hayashi N, Yuki N, Hagiwara H, Kato M, Yamamoto K, Eguchi H, Fusamoto H, Masuzawa M, Kamada T. Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients. J Hepatol 1994; 21: 509-14.
17. Watanabe A, Nishimori H, Tsukishiro T, Okada K, Shimizu Y, Nambu S, Miyabayashi C, Takahara T, Higuchi K. Hepatocellular carcinoma in 13 patients with hepatitis C virus-associated chronic hepatitis. J Gastroenterol Hepatol 1994; 9: 30-4.
18. Sato S, Fujiyama S, Tanaka M, Yamasaki K, Kuramoto I, Kawano S, Sato T, Mizuno K, Nonaka S. Coinfection of hepatitis C virus in patients with chronic hepatitis B virus infection. J Hepatol 1994; 21: 159-66.
19. Hammel P, Marcellin P, Martinot-Peignoux M, Pham BN, Degott C, Level R, Lefort V, Benhallem A, Erlinger S, Benhamou JP. Etiology of chronic hepatitis in France: predominant role of hepatitis C virus. J Hepatol 1994; 21: 618-23.
20. Tsai JF, Margolis HS, Jeng JE, Ho MS, Chang WY, Lin ZY, Tsai JH. Circulating immune complexes in chronic hepatitis related to hepatitis C and B viruses infection. Clin Immunol Immunopathol 1995; 75: 39-44.
21. Tsai JF, Jeng JE, Chang WY, Ho MS, Lin ZY, Tsai JH. Increased immunoglobulin-specific circulating immune complexes in patients co-infected with hepatitis C and hepatitis B. Medicine 1995; 74: 136-43.
22. Chen CJ, Tseng SF, Lu CF, Lin HC, You SL, Chen CS, Hwang SJ, Hsieh SF, Hsu ST. Current seroepidemiology of hepatitis D virus infection among hepatitis B surface antigen caniers of general and high-risk populations in Taiwan. J Med Virol 1992; 38: 97-101.
23. Tsai JF, Jeng JE, Chang WY, Lin ZY, Tsai JH. Antibodies to hepatitis E virus among Chinese patients with acute hepatitis in Taiwan. J Med Virol 1994; 43: 341-4.
24. Tsai JF, Jeng JE, Chang WY, Lin ZY, Tsai JH. Antibodies to hepatitis E and A viruses among patients with non-alcoholic chronic liver disease in Taiwan. Scand J Gastroenterol 1994; 29: 651-4.
25. Tsai JF, Margolis HS, Fields HA, Nainan OV, Chang WY, Tsai JH. Immunoglobulin and hepatitis B surface antigen-specific circulating immune complexes in chronic hepatitis with hepatitis delta virus infection. J Med Virol 1990; 30: 25-9.
26. International Group. Acute and chronic hepatitis revisited. Lancet 1977; ii: 914-9.
27. Rothman KJ. Modern Epidemiology. Boston: Little, Brown & Company, 1986: 311-26.
28. Wang LY, Cheng YW, Chou SJ, Hsieh LL, Chen CJ. Secular trend and geographical variation in hepatitis A infection and hepatitis B carrier rate among adolescents in Taiwan: an island-wide survey. J Med Virol 1993; 39: 1-5.
29. Sheu JC, Wang JT, Wang TH, Wang CY, Yang PM, Huang GT, Shih LN, Lee HS, Chen DS. Prevalence of hepatitis C viral infection in a community in Taiwan: detection by synthetic peptide-based assay and polymerase chain reaction. J Hepatol 1993; 17: 192-8.
30. Suzuki H. Viral hepatitis in Japan. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral Hepatitis and Liver Disease. Tokyo: Springer Verlag 1994: 426-8.
31. Lin HH, Hsu HY, Chang MH, Hong KF, Young YC, Lee TY, Chen PJ, Chen DS. Low prevalence of hepatitis C virus and infrequent perinatal or spouse infections in pregnant women in Taiwan. J Med Virol 1991; 35: 237-40.
32. Wu JC, Lin HC, Jeng FS, Ma GY, Lee SD, Sheng WY. Prevalence, infectivity, and risk factor analysis of hepatitis C virus infection in prostitutes. J Med Virol 1993; 39: 312-7.
33. Fong TL, Di Bisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 1991; 14: 64-7.
34. Chu CM, Sheen IS, Liaw YF. The role of hepatitis C virus in fulminant hepatitis in an area with endemic hepatitis A and B. Gastroenterology 1994; 107: 189-95.
35. Liaw YF, Lin SM, Sheen IS, Chu CM. Acute hepatitis C virus superinfection followed by spontaneous HBsAg seroconversion and HBsAg elimination. Infection 1991; 19: 250-1.